Bayesian Health vs Cytovale IntelliSep
Two approaches to the same question, is this patient becoming septic, and they take opposite routes to the answer. Cytovale measures the patient: a cleared in vitro diagnostic that assesses sepsis probability from the mechanical behaviour of the patient's own white blood cells, running on a self contained instrument with a first in class clearance and a published intermediate band that lets the test decline to call it. Bayesian Health reads the record, running machine learning inside the electronic health record continuously, with the deepest prospective evidence base in this index. The practical difference is when and where. In an emergency department, with a patient nobody has data on, a blood test answers and a record based model cannot. On an inpatient ward over three days, continuous monitoring catches what a single draw at admission could not.
- The whole product is a prediction from a routine blood draw rather than from the record, so it works for a patient with no history at that institution, which is exactly the emergency department case.
- The clearance is first in class with a precisely bounded indication, and the intermediate band functions as a published abstention mechanism rather than forcing a binary call.
- It runs on a self contained instrument, so there is no integration project and no dependence on the completeness of the chart.
- Three large prospective multi site cohort studies with a major academic health system, which is the strongest evidence base of any vendor in this index.
- It monitors continuously across the admission rather than at a single moment, so a patient who deteriorates hours after arrival is still covered.
- It runs inside the record system on data already being collected, with no consumable cost per patient and no instrument to site.
Side by Side
| Axis | B Bayesian Health |
C Cytovale IntelliSep |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
These products answer the same clinical question at different moments and with different economics, so a hospital may reasonably deploy both: one is a point in time test with a per test cost, the other is continuous monitoring with an integration cost.
Neither publishes subgroup performance or calibration analysis, and for a test measuring cellular mechanical behaviour the specific exposure is that conditions affecting white cell behaviour, including chronic inflammatory disease and recent chemotherapy, may shift results independently of infection. Bayesian publishes no security attestation, business associate posture or pricing. Cytovale publishes no instrument, cartridge or per test price.